Altium Capital Management LP discloses 4.99% ownership in ORMP / Oramed Pharmaceuticals, Inc.

February 14, 2020 - Altium Capital Management LP has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 972,000 shares of Oramed Pharmaceuticals, Inc. (US:ORMP). This represents 4.99 percent ownership of the company. In their previous filing dated February 13, 2019, Altium Capital Management LP had reported owning 751,494 shares, indicating an increase of 29.34 percent.

13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

Related News Stories

CUSIP: 68403P203 ISIN: US68403P2039